Purpose

Healthcare providers (HCP) serving the El Paso U.S.-Mexico Border Region will be recruited to compare educational and professional skills interventions focused on the human papillomavirus (HPV). Our hypothesis is that improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among the populations they serve.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 65 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Current (in practice) or emerging (in training - medical student, resident, or fellow) healthcare provider - Working/training or living in the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico) - Have the authorization to recommend/prescribe/administer the HPV vaccine

Exclusion Criteria

  • Unaffiliated with the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico) - Participation in Phases I or II of the larger research project [cross-sectional phases] - Does not identify as a current or emerging healthcare provider - Declines or is unable to participate in the full intervention and follow-up time-points - Unable to complete participation and activities in the English language

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
A parallel trial design will be used to examine the effectiveness of a tailored HPV education and professional skills intervention. Emerging and current healthcare providers will be randomly assigned to one of two conditions: 1) treatment condition in which they will receive a tailored Education and Professional Skills Intervention, and 2) control condition in which they will receive general, publicly available information about HPV and communication skills. Participants will then be followed over time and the responses will be compared between groups.
Primary Purpose
Other
Masking
Double (Participant, Outcomes Assessor)
Masking Description
Participants [blinding]: participants will be randomly assigned to treatment and control groups, they will not be made aware of other participant's receipt of treatment or control materials. Participants will be asked not to discuss this project outside of the intervention; delivery of the intervention or other educational materials will be virtual, limiting the ability of participants to interact with one another during the study. Outcome assessor [blinding]: to reduce bias in the implementation and assessment of the clinical trial, participant information and pre-post survey responses will be maintained separately from the assignment and delivery of the intervention.

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Treatment
A tailored HPV education and professional skills intervention.
  • Behavioral: Tailored HPV Education and Professional Skills Intervention Group
    The provider education and professional skills intervention will involve audio and visual content and will be delivered in the English language.
Active Comparator
Control
General/publicly available educational materials on HPV and communication skills.
  • Behavioral: General HPV Education and Communication Skills Control Group
    The general provider education intervention will involve audio and visual content and will be delivered in the English language.

Recruiting Locations

Burrell College of Osteopathic Medicine
Las Cruces, New Mexico 88001
Contact:
Burrell College Office of Research and Sponsored Programs
575-674-2338
research@bcomnm.org

The University of Texas at El Paso, Border Biomedical Research Center
El Paso, Texas 79968
Contact:
Border Biomedical Research Center
915-747-5536
bbrc@utep.edu

More Details

NCT ID
NCT05120869
Status
Recruiting
Sponsor
University of Texas, El Paso

Study Contact

Kristin Gosselink, PhD
575-674-2335
kgosselink@burrell.org

Detailed Description

A sample of emerging [in training] and current [in practice] health professionals from the El Paso U.S.-Mexico Border Region will be recruited to participate in a human papillomavirus (HPV) educational and professional skills intervention. Hypothesis: improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among eligible individuals through a tailored multi-media intervention to strengthen providers' ability to discuss HPV and vaccination in an informed and culturally competent manner, and increase subsequent provider recommendations.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.